Literature DB >> 31077083

Progress in understanding youth-onset type 2 diabetes in the United States: recent lessons from clinical trials.

Philip Zeitler1.   

Abstract

BACKGROUND: Due to the dramatic increase in the rates of childhood obesity and youth-onset type 2 diabetes (T2D) in the late 1990s in the United States, the US government, through the National Institute of Diabetes, Digestive Disease, and Kidney (NIDDK) and the Centers for Disease Control, funded a series of large studies and trials which, together, have formed the basis for much of what we currently understand about youth-onset T2D. DATA SOURCES: The review focus on the recent results and implications of the treatment options for Type 2 Diabetes in Adolescents and Youth (TODAY) study and the Restoring Insulin Secretion (RISE) study. RESULTS AND
CONCLUSIONS: Both TODAY and RISE studies have provided critical insight into the unique aspects of the pathophysiology of youth-onset type 2 diabetes and also provided the evidence base for our current approach to the management of this disorder.

Entities:  

Keywords:  Insulin resistance; Insulin sensitivity; Obesity; Type 2 diabetes

Mesh:

Year:  2019        PMID: 31077083     DOI: 10.1007/s12519-019-00247-1

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  36 in total

Review 1.  Glucolipotoxicity: fuel excess and beta-cell dysfunction.

Authors:  Vincent Poitout; R Paul Robertson
Journal:  Endocr Rev       Date:  2007-11-29       Impact factor: 19.871

2.  Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin.

Authors:  Abbas E Kitabchi; Marinella Temprosa; William C Knowler; Steven E Kahn; Sarah E Fowler; Steven M Haffner; Reuben Andres; Christopher Saudek; Sharon L Edelstein; Richard Arakaki; Mary Beth Murphy; Harry Shamoon
Journal:  Diabetes       Date:  2005-08       Impact factor: 9.461

3.  A school-based intervention for diabetes risk reduction.

Authors:  Gary D Foster; Barbara Linder; Tom Baranowski; Dan M Cooper; Linn Goldberg; Joanne S Harrell; Francine Kaufman; Marsha D Marcus; Roberto P Treviño; Kathryn Hirst
Journal:  N Engl J Med       Date:  2010-06-27       Impact factor: 91.245

4.  Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline.

Authors:  Kenneth C Copeland; Philip Zeitler; Mitchell Geffner; Cindy Guandalini; Janine Higgins; Kathryn Hirst; Francine R Kaufman; Barbara Linder; Santica Marcovina; Paul McGuigan; Laura Pyle; William Tamborlane; Steven Willi
Journal:  J Clin Endocrinol Metab       Date:  2010-10-20       Impact factor: 5.958

5.  A clinical trial to maintain glycemic control in youth with type 2 diabetes.

Authors:  Phil Zeitler; Kathryn Hirst; Laura Pyle; Barbara Linder; Kenneth Copeland; Silva Arslanian; Leona Cuttler; David M Nathan; Sherida Tollefsen; Denise Wilfley; Francine Kaufman
Journal:  N Engl J Med       Date:  2012-04-29       Impact factor: 91.245

6.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

7.  Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial.

Authors:  Jianping Weng; Yanbing Li; Wen Xu; Lixin Shi; Qiao Zhang; Dalong Zhu; Yun Hu; Zhiguang Zhou; Xiang Yan; Haoming Tian; Xingwu Ran; Zuojie Luo; Jing Xian; Li Yan; Fangping Li; Longyi Zeng; Yanming Chen; Liyong Yang; Sunjie Yan; Juan Liu; Ming Li; Zuzhi Fu; Hua Cheng
Journal:  Lancet       Date:  2008-05-24       Impact factor: 79.321

8.  Insulin resistance in adolescents with type 2 diabetes is associated with impaired exercise capacity.

Authors:  Kristen J Nadeau; Phillip S Zeitler; Timothy A Bauer; Mark S Brown; Jennifer L Dorosz; Boris Draznin; Jane E B Reusch; Judith G Regensteiner
Journal:  J Clin Endocrinol Metab       Date:  2009-07-07       Impact factor: 5.958

9.  Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes.

Authors:  P Zeitler; L Epstein; M Grey; K Hirst; F Kaufman; W Tamborlane; D Wilfley
Journal:  Pediatr Diabetes       Date:  2007-04       Impact factor: 4.866

10.  Glomerular hyperfiltration and renal disease progression in type 2 diabetes.

Authors:  Piero Ruggenenti; Esteban L Porrini; Flavio Gaspari; Nicola Motterlini; Antonio Cannata; Fabiola Carrara; Claudia Cella; Silvia Ferrari; Nadia Stucchi; Aneliya Parvanova; Ilian Iliev; Alessandro Roberto Dodesini; Roberto Trevisan; Antonio Bossi; Jelka Zaletel; Giuseppe Remuzzi
Journal:  Diabetes Care       Date:  2012-07-06       Impact factor: 19.112

View more
  3 in total

1.  Big challenges: obesity and type 2 diabetes in children and adolescents.

Authors:  Jun-Fen Fu
Journal:  World J Pediatr       Date:  2019-08       Impact factor: 2.764

2.  Bone Mass and Density in Youth With Type 2 Diabetes, Obesity, and Healthy Weight.

Authors:  Joseph M Kindler; Andrea Kelly; Philip R Khoury; Lorraine E Levitt Katz; Elaine M Urbina; Babette S Zemel
Journal:  Diabetes Care       Date:  2020-08-10       Impact factor: 19.112

3.  Efficacy of metformin and fermentable fiber combination therapy in adolescents with severe obesity and insulin resistance: study protocol for a double-blind randomized controlled trial.

Authors:  Edward C Deehan; Eloisa Colin-Ramirez; Lucila Triador; Karen L Madsen; Carla M Prado; Catherine J Field; Geoff D C Ball; Qiming Tan; Camila Orsso; Irina Dinu; Mohammadreza Pakseresht; Daniela Rubin; Arya M Sharma; Hein Tun; Jens Walter; Christopher B Newgard; Michael Freemark; Eytan Wine; Andrea M Haqq
Journal:  Trials       Date:  2021-02-17       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.